Get the Stockscreener App
30.52
2.38%
0.71
After Hours:
30.52
Azenta Inc stock is traded at $30.52, with a volume of 321.95K.
It is up +2.38% in the last 24 hours and up +2.90% over the past month.
Azenta Inc is a provider of life sciences solutions, enabling impactful breakthroughs and therapies to market faster. It provides a full suite of reliable cold-chain sample management solutions and genomic services across areas such as drug development, clinical research and cell therapies for the industry's top pharmaceutical, biotech, academic and healthcare institutions globally. The company has three reportable segments that are Sample Management Solutions, Multiomics, and B Medical Systems. It generates a substantial part of its revenue from its Sample Management Solutions segment.
See More
Previous Close:
$29.81
Open:
$30.15
24h Volume:
321.95K
Relative Volume:
0.53
Market Cap:
$1.40B
Revenue:
$604.93M
Net Income/Loss:
$-31.91M
P/E Ratio:
-12.61
EPS:
-2.42
Net Cash Flow:
$45.67M
1W Performance:
-4.03%
1M Performance:
+2.90%
6M Performance:
+14.26%
1Y Performance:
-32.61%
1-Day Range:
$29.65
$30.71
1-Week Range:
$29.52
$32.43
52-Week Range:
$23.91
$55.63
Azenta Inc Stock (AZTA) Company Profile
Name
Azenta Inc
Sector
Industry
Phone
(978) 262-2400
Address
200 SUMMIT DRIVE, BURLINGTON
Compare AZTA with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
AZTA
Azenta Inc
|
30.52 | 1.37B | 604.93M | -31.91M | 45.67M | -2.42 |
|
ISRG
Intuitive Surgical Inc
|
435.73 | 154.00B | 9.15B | 2.63B | 1.99B | 7.1661 |
|
BDX
Becton Dickinson Co
|
186.66 | 53.47B | 21.39B | 1.61B | 2.55B | 5.5609 |
|
RMD
Resmed Inc
|
273.01 | 39.70B | 5.15B | 1.40B | 1.65B | 9.5082 |
|
ALC
Alcon Inc
|
72.60 | 35.62B | 10.03B | 1.07B | 1.39B | 2.1549 |
|
WST
West Pharmaceutical Services Inc
|
262.47 | 18.82B | 2.96B | 487.70M | 344.00M | 6.6758 |
Azenta Inc Stock (AZTA) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Aug-06-25 | Upgrade | Raymond James | Mkt Perform → Outperform |
| Jul-22-25 | Resumed | Stephens | Equal-Weight |
| Dec-18-24 | Upgrade | Stephens | Equal-Weight → Overweight |
| Apr-04-24 | Initiated | Jefferies | Hold |
| Feb-01-24 | Reiterated | B. Riley Securities | Buy |
| Jul-19-23 | Initiated | Raymond James | Mkt Perform |
| May-10-23 | Downgrade | KeyBanc Capital Markets | Overweight → Sector Weight |
| Feb-09-23 | Downgrade | Stephens | Overweight → Equal-Weight |
| Jan-03-23 | Downgrade | Evercore ISI | Outperform → In-line |
| Mar-31-22 | Resumed | B. Riley Securities | Buy |
| Mar-21-22 | Initiated | Evercore ISI | Outperform |
View All
Azenta Inc Stock (AZTA) Latest News
Azenta Inc. stock daily chart insightsDollar Strength & Free Reliable Trade Execution Plans - newser.com
Regression analysis insights on Azenta Inc. performanceJuly 2025 Snapshot & Daily Profit Maximizing Tips - newser.com
Applying big data sentiment scoring on Azenta Inc.2025 Key Lessons & Breakout Confirmation Alerts - newser.com
Azenta Inc. recovery potential after sell off2025 Fundamental Recap & Technical Buy Zone Confirmation - newser.com
Automated trading signals detected on Azenta Inc.July 2025 Decliners & Weekly Market Pulse Updates - newser.com
LifeStance Health Group, Azenta, PacBio, GE HealthCare, and ICU Medical Shares Are Falling, What You Need To Know - The Globe and Mail
Is Azenta Inc. stock entering bullish territoryTrend Reversal & Low Volatility Stock Recommendations - newser.com
Published on: 2025-10-10 09:48:18 - newser.com
Custom watchlist performance reports with Azenta Inc.July 2025 Pullbacks & Verified Momentum Stock Watchlist - newser.com
Why Azenta Inc. stock is a must watch in 2025July 2025 Update & Safe Entry Zone Identification - newser.com
Azenta's (AZTA) Sell (D-) Rating Reaffirmed at Weiss Ratings - MarketBeat
Global Biopreservation Market Set to Surpass USD 7.1 Billion by 2029 | MarketsandMarkets™ - GlobeNewswire Inc.
State of Alaska Department of Revenue Raises Holdings in Azenta, Inc. $AZTA - Defense World
What analysts say about Azenta Inc stockStock Buy Signals & Low Cost Stock Picks - earlytimes.in
Azenta, Inc. (AZTA) Stock Analysis: Navigating a Challenging Landscape with Growth Potential - DirectorsTalk Interviews
Azenta, Inc. $AZTA Shares Bought by Farther Finance Advisors LLC - Defense World
Will Azenta Inc. (BA3) stock sustain dividend payouts2025 Top Decliners & Free High Return Stock Watch Alerts - newser.com
Can momentum traders help lift Azenta Inc.Bull Run & Verified Technical Signals - newser.com
Key metrics from Azenta Inc.’s quarterly dataEarnings Overview Summary & Advanced Technical Signal Analysis - newser.com
Analysts Set Azenta, Inc. (NASDAQ:AZTA) PT at $35.75 - Defense World
Why Azenta Inc. (BA3) stock could be top winnerTrend Reversal & Consistent Growth Stock Picks - newser.com
Can Azenta Inc. stock beat market expectations this quarterWatch List & Momentum Based Trading Ideas - newser.com
Is now a turning point for Azenta Inc.2025 Price Action Summary & Comprehensive Market Scan Insights - newser.com
Market reaction to Azenta Inc.’s recent newsMarket Sentiment Summary & Risk Adjusted Buy/Sell Alerts - newser.com
What MACD signals say about Azenta Inc.July 2025 Earnings & Verified High Yield Trade Plans - newser.com
Analyzing Azenta Inc. with risk reward ratio chartsJuly 2025 Opening Moves & Real-Time Market Sentiment Alerts - newser.com
Can trapped investors hope for a rebound in Azenta Inc.Weekly Risk Summary & AI Optimized Trading Strategy Guides - newser.com
Strong week for Azenta (NASDAQ:AZTA) shareholders doesn't alleviate pain of five-year loss - simplywall.st
Azenta, Inc. (NASDAQ:AZTA) Given Consensus Recommendation of "Hold" by Analysts - MarketBeat
How Azenta Inc. (BA3) stock behaves in tightening cycles2025 Growth vs Value & Fast Gain Stock Trading Tips - newser.com
Using RSI to spot recovery in Azenta Inc.Weekly Investment Report & Stock Portfolio Risk Management - newser.com
Azenta Inc Stock (AZTA) Financials Data
Revenue
Net Income
Cash Flow
EPS
2.84%
3.32%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):